Portland State Business Accelerator Mt. Hood room

Hey, it's 12/12/12, and time for another evening of games with Comic Rocket! We've been doing this monthly since September and it's been awesome, so it's time to do it again!

We're bringing our game libraries, including Risk, Blokus, Magic: The Gathering, Ricochet Robots, Order of the Stick, and many more games. Please bring anything you want to play too!

We'll provide snacks and drinks. Last month people self-organized a group pizza order as well, and if you'd like to participate this month, you have the power. :-)

Oregon Bioscience Association has a very special guest speaking on Non-Dilutive Funding, Ram May-Ron, Managing Partner, FreeMind Group from Boston. We would like to invite you to join us for a 1 hour presentation, and an opportunity to meet one on one with Mr. May-Ron afterward about NIH/DOD Funding Opportunities.

When: July 18th, Presentation 8:00 a.m. to 9:00 a.m.  Direct meetings to follow. To register for one on one meetings please email: casey@freemindconsultants.com

FreeMind is the largest consulting group of its kind whose goal is to assist its clients in maximizing their potential to secure funding from non-dilutive sources. Established in 1999, FreeMind's proven long-term strategic approach has garnered its clients, academics and Industry alike, over $1.5 Billion to date. Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH Institutes, DOD, BARDA, etc., as well as private foundations. FreeMind's knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding its clients' non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our team of experts will assist in making non-dilutive funding a key tool in a long-term financial strategy.

The Research and Development Tax Credit – Benefits, Caveats, and Strategies

Recently, The Fiscal Times identified the research and development tax credit as #8 of the 10 largest big corporate tax breaks*. Although over 17,000 companies claim this credit nationwide, 100 large multinationals receive over half of the 7+ billion dollars in savings each year. Find out what your company can do to receive the same level of benefit the Fortune 100 have been receiving for years.

Many medical device, software, and biotech companies eligible to benefit handsomely from this credit have never applied for it, or are only receiving a small fraction of what they are eligible for. R&D credits reimburse the costs associated with a company’s breakthroughs, as well as the day-to-day activities that bring improvements in products, software, processes, profits, and productivity. The research and development credit was enacted to encourage innovation, and applies to activities throughout an organization – from conceptualization, prototyping and production, through testing and the planning of quality control.

Specific coverage will include:

Identifying qualifying activities throughout your company.

Early stage companies - why it is never too early to claim the credit.

How to effectively lower the cost of process improvement, product testing, patent applications, and other activities not commonly considered as R&D.

Credits for contract manufacturing – the companies who design devices and create software aren’t the only ones eligible.

Potential risks and strategies for getting the most out of the credit.

Who should attend:

CFO’s, controllers, in-house counsel, and others involved in financial management.

Accountants and tax attorneys.

Company owners, angel investors, venture capitalists, seed fund managers, and other investors looking to maximize their investment returns.

Patent attorneys, operational consultants, Lean gurus, and test, and design firms interested in educating their clients on a credit that can effectively lower their service costs.